-
41
Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
Published 2021-07-01Subjects: “…multiple myeloma…”
Get full text
Article -
42
Long-term trends in the burden of multiple myeloma in China: a Joinpoint regression and age-period-cohort analysis based on GBD 2021
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
43
5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
Published 2024-12-01Subjects: Get full text
Article -
44
Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
45
The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen
Published 2025-01-01Subjects: Get full text
Article -
46
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
47
Unveiling causal immune cell–gene associations in multiple myeloma: insights from systematic reviews and Mendelian randomization analyses
Published 2025-01-01Subjects: Get full text
Article -
48
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Published 2025-01-01Subjects: Get full text
Article -
49
PNPO‐Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β‐Catenin Pathway
Published 2025-02-01Subjects: Get full text
Article -
50
Detection of early relapse in multiple myeloma patients
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
51
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
Published 2024-12-01Subjects: Get full text
Article -
52
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Published 2025-02-01Subjects: Get full text
Article -
53
Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report
Published 2025-01-01Subjects: Get full text
Article -
54
A Nomogram Based on Circulating Inflammatory Factors for Predicting Prognosis of Newly Diagnosed Multiple Myeloma Patients
Published 2025-02-01Subjects: “…multiple myeloma…”
Get full text
Article -
55
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads
Published 2025-01-01Subjects: Get full text
Article -
56
Unmasking Multiple Myeloma: The Importance of Suspecting Malignancy in Atypical Chronic Pain Mimicking Degenerative Conditions—A Case Report
Published 2025-01-01Subjects: Get full text
Article -
57
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach
Published 2025-01-01Subjects: “…Multiple myeloma…”
Get full text
Article -
58
Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients wit...
Published 2025-01-01Subjects: “…multiple myeloma…”
Get full text
Article -
59
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
Published 2025-01-01Subjects: Get full text
Article -
60
Correlation between Neutrophil Gelatinase Associated with Lipocaline and Beta-2 Microglobulin with Other Renal Markers in Iraqi Patients with Multiple Myeloma
Published 2022-11-01Subjects: “…Multiple myeloma (MM)…”
Get full text
Article